Myths about vitamin B12 deficiency

Area of Science:

• Neurology
• Hematology
• Clinical Medicine

Background:

• Vitamin B12 deficiency presents with diverse neurologic symptoms, including neuropathy, depression, and dementia.
• Common diagnostic indicators like hematologic indices and the Schilling test can be misleading, appearing normal in up to 30% of affected individuals.
• Neurologic manifestations can arise independently or concurrently, affecting both peripheral nerves and the spinal cord.

Purpose of the Study:

• To clarify common misconceptions surrounding vitamin B12 deficiency.
• To emphasize the importance of recognizing neurologic symptoms indicative of vitamin B12 deficiency, irrespective of standard lab results.
• To advocate for timely vitamin B12 replacement therapy.

Main Methods:

• Review of clinical evidence and diagnostic challenges associated with vitamin B12 deficiency.
• Analysis of the presentation and pathology of vitamin B12-related neuropathy and myelopathy.
• Evaluation of treatment outcomes and therapeutic recommendations.

Main Results:

• Hematologic indices and Schilling test results are not always reliable indicators of vitamin B12 deficiency.
• Neuropathy, primarily axonal and sensory, and myelopathy, resulting from demyelination in the posterior and lateral columns, are key neurologic manifestations.
• Recovery from neuropathy after treatment is often slow and incomplete.

Conclusions:

• Vitamin B12 deficiency can manifest neurologically even when hematologic parameters are normal.
• Treatment with vitamin B12 should be initiated promptly, even with borderline levels, to prevent irreversible neurologic damage.
• The risks associated with untreated or undertreated vitamin B12 deficiency, including worsening neurologic and mental disorders, significantly outweigh the potential disadvantages of therapy.